We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GNTA market cap is 74.33M. The company's latest EPS is EUR -0.5829 and P/E is -7.00.
| Quarter End | |||||
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 998k | 1.19M | 465k |
| Operating Income | -4.63M | -5.59M | -9.1M | -10.06M | -10.77M |
| Net Income | -4.6M | -5.59M | -9.1M | -7.68M | -10.62M |
| Quarter End | |||||
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 21.35M | 17.5M | 43.01M | 36.54M | 25.19M |
| Total Liabilities | 2.5M | 2.35M | 1.11M | 2.32M | 1.59M |
| Total Equity | 18.85M | 15.15M | 41.89M | 34.22M | 23.6M |
| Market Cap | 74.33M |
| Price to Earnings Ratio | -7.00 |
| Price to Sales Ratio | 160 |
| Price to Cash Ratio | 24.49 |
| Price to Book Ratio | 3.15 |
| Dividend Yield | - |
| Shares Outstanding | 18.22M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.37 (9.09%) |
| Company Name | Genenta Science SPA |
| Address |
via olgettina, 58 milan, lombardy 20132 |
| Website | https://www.genenta.com |
| Industry | health practitioners, nec (8049) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
